![Yvonne Yamanaka](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yvonne Yamanaka
Directeur/Membre du Conseil chez
Immpact Bio USA, Inc.
Profil
Yvonne Yamanaka currently works at ImmPACT Bio USA, Inc., as Director from 2022 and venBio Partners LLC, as Partner.
Dr. Yamanaka also formerly worked at Artiva Biotherapeutics, Inc., as Independent Director.
Dr. Yamanaka received her undergraduate degree in 2008 from Duke University and doctorate degree in 2014 from Massachusetts Institute of Technology.
Postes actifs de Yvonne Yamanaka
| Sociétés | Poste | Début |
|---|---|---|
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Directeur/Membre du Conseil | 20/01/2022 |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Private Equity Investor | 01/08/2016 |
Anciens postes connus de Yvonne Yamanaka
| Sociétés | Poste | Fin |
|---|---|---|
| ARTIVA BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Formation de Yvonne Yamanaka
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Immpact Bio USA, Inc.
Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
